CSI Market
Sign In | Register

Novo Integrated Sciences Inc (NVOS) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access NVOS Annual Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Novo Integrated Sciences Inc's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Aug 31 2024)
12 Months 		(May 31 2024) (Feb 29 2024) (Nov 30 2023) (Aug 31 2023)
Operating Activities
Income-16.13
Depreciation & amortization2.26
Amortization of Other Assets6.57
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges1.76
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.21
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.20
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), before Tax, Total1.59
Common Stock And Long Term Debt Issued For Acquisition Of License Agreement-
Common Stock Issued For Services And Amortization Of Common Stock Issued For Service-
Write Off Of Deferred Offering Costs-
Write Off Of Deferred Noncash Offering Costs-
Amortization Of Agency Fee-
Common Stock Issued In Exchange For Services-
Common Stock Issued In Exchange For Accrued Royalties-
Receivable Issued For Exercise Of Common Stock Options-
Noncash Or Part Noncash Acquisition Fixed Assets Acquired-
Stock Issued During Period Value Issued For Services-
Amortization Of Deferred Offering Costs-
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value-
Expense Associated With Modified Stock Option Terms-
Fair Value Of Vested Stock Options0.15
Fair Value Option Changes In Fair Value Gain Loss-0.47
Financing Costs For Debt Extension0.47
Derivative Gain Loss On Derivative Net-
Default Payment And Interest Paid Through Common Share Issuance-
Cashless Exercise Of Warrants-
Assets Write Off-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.45
Increase (Decrease) in Accounts Payable-0.27
Accrued Expense0.61
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.26
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.06
Discontinued operations0.00
Net Cash flow from Operating Activities-5.07
Investing Activities
Capital Expenditures-0.01
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payment Of Agency Fee Rights-
Issuance Of Notes Receivable From Stockholders-
Repayment Of Notes Receivable From Stockholders-
Payments To Acquire Assets-
Payments For Proceeds Cash From Acquisition-
Payment On Other Receivable-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Other Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.01
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings8.65
Long-term debt - repayments-3.89
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.24
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Notes Payable-
Offering Cost Paid-
Repayments Of Debenture Related Party-
Repayments Of Finance Leases-
Finance Lease Principal Payments-0.01
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4.99
Effect of exchange rate on cash flow0.51
Discontinued operations0.00
Free Cash Flow-5.07
Total Cash Flow0.43
4 historic quarters locked

Sign in to unlock the full Novo Integrated Sciences Inc cash flow history.

Sign In Create Free Account

About Novo Integrated Sciences Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240531)
  • Filed with the SEC: July 19, 2024
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-24-028543

Figures are derived from filed reports and may be restated. Historical data is subject to revision.